The USC School of Pharmacy is a leading research and teaching institution. It is the top ranked private pharmacy school in the United States. In the most recent US News & World Report ranking of graduate programs in pharmacy the SOP placed 9th in the nation. The School’s graduate programs encompass a diverse community spanning the USC University Park and Health Sciences campuses.  As part of one of the world’s largest research universities, the School’s programs benefit from diverse course offerings, cutting-edge research and innovative thinking aiming to improve people’s lives. Students are part of this vibrant enterprise and their educational experience is punctuated by cross-discipline conversations and projects. Our intersecting areas of expertise allow for research and doctoral-level training in every aspect of therapeutic development from drug discovery, delivery and mechanism to translation and clinical testing, regulatory science, outcomes analysis and policy development.

The USC School of Pharmacy offers the following MS and PhD degrees:

Programs in Pharmaceutical and Translational Sciences (PHTS)

  • MS and PhD in Molecular Pharmacology and Toxicology (MPTX)
  • MS and PhD in Pharmaceutical Sciences (PSCI)
  • MS and PhD in Clinical and Experimental Therapeutics (CXPT)

Programs in Health Economics (HE)

  • MS in BioPharmaceutical Marketing (BPMK)
  • MS in Pharmaceutical Economics and Policy (PEP)
  • PhD in Health Economics (HE)
  • MS in Healthcare Decision Analysis (HCDA)

Programs in Regulatory Sciences

  • MS and Professional Doctorate (DRSc) in Regulatory Science
  • MS in the Management of Drug Development (MDD)
  • MS in Medical Product Quality (MPQ)
  • MS in Regulatory Management (MRM)

These programs enrolled a total of 473 students – including 93 PhD students, 38 DRSc students and 342 MS students, for the 2019-2020 academic year.

Additional Degree Opportunities

The USC School of Pharmacy offers additional degree programs which can be obtained concurrently with a PhD or Masters and offer additional value and experience relevant to career opportunities in industry and government. These include a dual PharmD/PhD, or a joint PhD degree with a Masters degree (e.g., in Regulatory Science, Management of Drug Development, or Healthcare Decision Analysis).